Hubbry Logo
PolydextrosePolydextroseMain
Open search
Polydextrose
Community hub
Polydextrose
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Polydextrose
Polydextrose
from Wikipedia
Gummy bears made with polydextrose

Polydextrose is a synthetic polymer of glucose.[1] It is a food ingredient classified as soluble fiber by the US FDA as well as Health Canada, as of April 2013. It is frequently used to increase the dietary fiber content of food, to replace sugar, and to reduce calories and fat content. It is a multi-purpose food ingredient synthesized from dextrose (glucose), plus about 10 percent sorbitol and 1 percent citric acid. Its E number is E1200. The FDA approved it in 1981.

It is one-tenth as sweet as sugar.[2]

History

[edit]

Commercial development of polydextrose began at Pfizer Central Research Laboratories in the late 1960s. Hans H. Rennhard created the material during research on low-calorie bulking agents made from glucose, sorbitol, and citric acid. Pfizer patented the process in 1973 through United States Patent 3,766,165. The U.S. Food and Drug Administration approved polydextrose as a food additive in 1981 under 21 CFR 172.841.[3][4]

Commercial uses

[edit]

Polydextrose is commonly used as a replacement for sugar, starch, and fat in commercial beverages, cakes, candies, dessert mixes, breakfast cereals, gelatins, frozen desserts, puddings, and salad dressings. Polydextrose is frequently used as an ingredient in low-carb, sugar-free, and diabetic cooking recipes. It is also used as a humectant, stabiliser, and thickening agent.

Polydextrose is a form of soluble fiber and has shown healthful prebiotic benefits when tested in animals. It contains only 1 kcal per gram, and it therefore also helps to reduce calories.

However, polydextrose is not universally well tolerated. Doses as low as 10 g cause significantly more intestinal gas and flatulence than fermentation resistant psyllium.[5]

References

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
from Grokipedia
Polydextrose is a synthetic, non-digestible and soluble widely used as a to replace and in low-calorie products. It is produced through the thermal of glucose in the presence of small amounts of and under vacuum conditions, yielding a randomly branched primarily composed of glucose units linked by α-(1→6) glycosidic bonds, with an average of about 12 and a molecular weight around 2,000 Da. This results in a white to light tan, water-soluble powder with a low caloric value of approximately 1 kcal/g, as it is not digested in the but fermented by in the colon to produce . As a versatile functional ingredient, polydextrose functions as a bulking agent, , stabilizer, and texturizer in various foods, including baked goods (up to 30%), (up to 95%), products (2-7%), and beverages (up to 10%), helping to maintain texture and while reducing calories and content. It is approved for use in over 60 countries, including as E 1200 in the under Regulation (EC) No 1333/2008 and in the United States under 21 CFR 172.841, approved by the FDA as a direct in 1981. Physiologically, it promotes bowel regularity by increasing stool bulk and frequency, enhances mineral absorption (such as calcium by 16-262% and iron by up to 74%), supports beneficial as a prebiotic, and may aid in blood glucose control and appetite regulation without significantly raising postprandial triglycerides. Safety evaluations confirm polydextrose is well-tolerated, with no genotoxic, carcinogenic, or reproductive toxicity concerns observed in animal studies at doses up to 15,000 mg/kg body weight per day; the Joint FAO/WHO Expert Committee on Food Additives (JECFA) and the European Food Safety Authority (EFSA) have established no numerical acceptable daily intake (ADI), deeming it safe at typical exposure levels up to 590 mg/kg body weight per day in high consumers like toddlers. Mild laxative effects may occur at intakes exceeding 90 g/day in adults or 50 g as a single dose, prompting regulatory advisories for products containing more than 25 g/100 g. Overall, it contributes to dietary fiber intake, recognized by methods like AOAC 2000.11, and supports health benefits such as improved gut function without posing safety risks at authorized levels.

Chemical Structure and Production

Molecular Composition

Polydextrose is a synthetic, randomly branched primarily composed of glucose units connected through various glycosidic bonds, including predominantly 1→6 linkages (both α- and β-) along with α- and β-1→2, 1→3, 1→4, and 1→6 bonds. This structure arises from the of D-glucose, resulting in a highly branched that lacks the regular repeating units found in natural like or . The irregular bonding pattern contributes to its resistance to enzymatic in the human gastrointestinal tract. During synthesis, small amounts of (approximately 10%) and (approximately 1%) are incorporated as branching agents and catalysts, respectively, with sorbitol serving as chain terminators to control molecular size and citric acid facilitating linkages. These components are bound within the matrix, with sorbitol end-groups and citric acid residues attached via mono- or diester bonds, enhancing the polymer's solubility and functionality. The input ratio of approximately 89:10:1 (D-glucose:sorbitol:citric acid) ensures the final product's composition supports its role as a versatile . The average (DP) of polydextrose is approximately 12, though it ranges from 2 to over 100 glucose units, leading to a weight-average molecular weight of about 2,000 Da, with most molecules falling between 1,200 and 2,000 Da and a distribution where roughly 89% have molecular weights below 5,000 Da. This polydisperse nature, characterized by a broad molecular weight range up to 20,000 Da, distinguishes it from uniform oligosaccharides and influences its physical properties. Polydextrose is classified as a non-digestible due to its random bonding that evades by human , and it is recognized as a soluble in regulatory frameworks across more than 60 countries. This dual classification underscores its utility as a low-calorie bulking agent in formulations.

Synthesis Process

Polydextrose is manufactured industrially through a process starting with dextrose (glucose) as the primary raw material, combined with approximately 10% and 1% to facilitate the reaction. The mixture is heated under conditions at temperatures between 160°C and 180°C for 3 to 4 hours, promoting the of glucose units while removing to drive the forward. This vacuum-melt approach minimizes side reactions and ensures the formation of a viscous, flowable mass suitable for further processing. The reaction mechanism relies on acid-catalyzed condensation, where the citric acid acts as both and branching agent, leading to random glycosidic linkages and a branched in the resulting low-molecular-weight product. The process yields a complex with an average around 12, though variations occur due to the non-stoichiometric nature of the bulk melt. This method emphasizes efficiency, achieving typical yields of 90-99% based on the input glucose, while the high-temperature vacuum setup requires significant input, typically managed through controlled heating systems in industrial reactors. Following , the crude product undergoes post-processing to refine it for commercial use, including neutralization with a base such as to adjust and inactivate residual acidity. Purification steps, such as filtration or ion-exchange treatment, remove unreacted monomers, color bodies, and byproducts, followed by drying—often via spray or vacuum drying—to produce a free-flowing with less than 4% moisture content. The overall process is highly scalable, supporting in large reactors for global food-grade supply, with optimizations like flash shear techniques reducing demands in downstream handling by eliminating traditional milling.

Physical and Functional Properties

Solubility and Stability

Polydextrose demonstrates exceptional in , enabling the formation of clear, colorless to straw-colored solutions with concentrations exceeding 80% w/w at 25 °C. This high aqueous , reported as up to 80% w/w at 20 °C for various commercial forms, facilitates its incorporation into and semi- systems without . It is also soluble in alcohols such as and partially soluble in polyols like glycerin and , but remains sparingly soluble or insoluble in most other organic solvents, limiting its use in non-aqueous formulations. The compound exhibits robust thermal stability, softening between 90–110 °C and melting above 130 °C, while maintaining integrity during production up to 260 °C before occurs. During typical , it withstands temperatures of 150–180 °C with minimal changes or degradation, and shows greater resistance to browning through Maillard reactions and than traditional sugars, thereby reducing the development of off-flavors in baked or heated products. Polydextrose is inherently hygroscopic, readily absorbing at relative exceeding 60%, which can lead to clumping if not managed. To preserve its free-flowing form, it requires storage in cool, dry environments below 60% relative humidity and away from direct heat or light, ensuring long-term stability for 2–3 years with negligible degradation. In terms of pH tolerance, polydextrose remains stable across a broad range of 2.5–7.0 in 10% aqueous solutions, with no significant under standard processing conditions at pH 3–7. This versatility supports its application in acidic beverages, neutral baked goods, and other formulations without compromising structural integrity.

Nutritional Characteristics

Polydextrose possesses a low caloric value of approximately 1 kcal/g, attributed to its resistance to by mammalian and subsequent incomplete by colonic , which limits extraction compared to fully digestible carbohydrates. This partial results in only about 50-90% fermentation, yielding a mean contribution of around 1.05 kcal/g across studies. Its glycemic index is very low, typically reported as 7 or below, leading to minimal impact on postprandial blood glucose and insulin levels even at intakes up to 56.7 g/day. This property makes polydextrose suitable for applications in low-glycemic formulations without significantly elevating blood sugar. Polydextrose is classified as a soluble in regulatory frameworks, including eligibility for declaration as such on nutrition labels by the U.S. FDA, due to its non-digestible nature and ability to provide bulk in the diet with negligible energy provision. It contributes to intake without the caloric of sugars or starches, supporting its use in fiber-enriched products. As a prebiotic, polydextrose exhibits selective by , particularly promoting growth of beneficial bacteria such as at doses as low as 4-8 g/day, while producing like , propionate, and butyrate through slow colonic breakdown. This fermentation profile enhances its role as a non-digestible with prebiotic functionality.

Health Effects and Physiology

Gastrointestinal Impact

Polydextrose is resistant to hydrolysis by human digestive enzymes in the small intestine due to its randomly bonded, complex structure, allowing it to pass largely intact into the large intestine where it undergoes gradual fermentation by colonic microbiota. Approximately 60% of ingested polydextrose is excreted in the feces, with the remainder partially fermented to produce short-chain fatty acids, contributing a low energy value of 1 kcal/g. This fermentation process extends to the distal colon, modifying the composition of the gut microbiota and supporting overall gastrointestinal function. As a prebiotic, polydextrose promotes the growth of beneficial , such as Bifidobacterium species, and is positively correlated with increased fecal levels of these microbes, enhancing microbial diversity in the colon. Its complex structure requires a diverse array of colonic for , thereby fostering a balanced ecosystem. While polydextrose alone exhibits moderate bifidogenicity, its effects on beneficial are evident in human studies, contributing to improved gut health. Polydextrose influences bowel regularity by increasing stool bulk and softening consistency, which helps alleviate constipation. Supplementation at doses like 12 g per day has been shown to increase the number of bowel movements by more than two per week, reduce straining, and promote complete evacuations in adults. In individuals with infrequent bowel habits, polydextrose can reduce transit time by up to 90% and raise weekly defecation frequency from three to seven times. Tolerance to polydextrose in the gastrointestinal tract is high, with the Joint FAO/WHO Expert Committee on Food Additives establishing a mean laxative threshold of approximately 90 g per day for most adults, beyond which minimal laxative effects may occur. At typical intake levels of 8–12 g per day, it causes no significant adverse gastrointestinal symptoms and is well-tolerated.

Metabolic Benefits

Polydextrose attenuates postprandial blood glucose and insulin responses by delaying carbohydrate absorption in the small intestine, leading to a more gradual release of glucose into the bloodstream. In a randomized controlled trial involving healthy adults, consumption of 56.7 g/day polydextrose significantly reduced peak postprandial glucose levels (p=0.06) and insulin excursions (p=0.02) compared to a control. Another acute study in overweight participants showed that 15 g polydextrose incorporated into a high-fat meal elevated glucagon-like peptide-1 (GLP-1) secretion (p=0.02), which contributes to improved insulin sensitivity and glucose regulation without altering ghrelin or peptide YY levels. Polydextrose also contributes to reductions in serum and through mechanisms including sequestration in the gut, which increases fecal excretion and prompts hepatic conversion to , and the production of that modulate . Human studies have demonstrated that daily intake of 12.5–15 g polydextrose lowers postprandial levels (p<0.05), with similar effects observed in hypercholesterolemic individuals where total and decreased. In animal models fed a Western diet, 14 days of polydextrose supplementation reduced by approximately 38% and total by 12%, linked to upregulated expression of intestinal lipid-regulating genes like Fxr. The fiber's potential in stems from enhanced and reduced intake, as polydextrose slows gastric emptying and stimulates appetite-suppressing hormones. Acute human interventions indicate dose-dependent reductions in subsequent energy intake by 5–17% with 10–21 g polydextrose, without compensatory , and meta-analyses confirm modest suppression (standardized mean difference 0.24–0.35). Clinical trials in and obese adults further show that 21 g/day polydextrose, often combined with , decreases body fat mass by up to 4.5% (p=0.02) and circumference by 2.7% (p=0.047) over 12 weeks, alongside lower of about 210 kcal/day. Evidence from clinical studies supports polydextrose's role in improving markers of and , such as fasting glucose and . In individuals with impaired glucose , regular polydextrose intake has lowered glycemic responses and enhanced insulin sensitivity, with one reporting 40–49% reductions in fasting glucose in diabetic mouse models. participants consuming polydextrose exhibited decreased ratings by 40% (p=0.03). Additionally, polydextrose enhances mineral absorption, with human studies showing increases in calcium absorption by 16-262% and iron by up to 74%, supporting health and preventing deficiencies.

Applications and Uses

Food Industry Applications

Polydextrose serves as a versatile functional ingredient in the , primarily functioning as a low-calorie bulking agent and replacer to preserve product texture and volume in reduced- formulations. Its high allows for seamless integration into diverse recipes without significantly altering or appearance. Typical dosage levels range from 5% to 20% in most formulations, though higher concentrations up to 30% or even 95% in are possible depending on the desired consistency. In baked goods such as breads, cakes, cookies, and muffins, polydextrose replaces and to maintain structural integrity, moisture retention, and overall volume during processing and storage. For and reduced-sugar chocolates, it acts as a bulking agent that prevents and cold flow, ensuring a smooth texture and extended ; commercial examples include sucrose-free milk chocolates incorporating polydextrose alongside sweeteners like . In beverages, it provides bulk without increasing , supporting the development of low-calorie functional drinks. Polydextrose enhances and in low-fat products, such as yogurts and s, where it mimics the creaminess of full-fat versions by improving water-holding capacity and textural smoothness. It is commonly added to ice cream mixes as a replacer and stabilizer to control meltdown and preserve scoopability. In fiber-fortified cereals and bars, polydextrose boosts nutritional profiles while sustaining crispness and chewiness; for instance, it is used in sugar-reduced cereals and snack bars to replace calories without compromising . Similarly, in sauces and dressings, it increases and acts as a bulking agent to achieve desired thickness and stability.

Health and Nutritional Uses

Polydextrose is commonly formulated into prebiotic supplements, drinks, and meal replacements to support gut health and weight control due to its low-calorie, non-digestible properties that promote beneficial activity. These products leverage polydextrose's prebiotic potential to nourish gut bacteria, enhancing microbial diversity and short-chain production, which contributes to improved digestive regularity and signals for management. For instance, a single 15 g dose of polydextrose has been shown to reduce perceptions in obese individuals. In medical nutrition, polydextrose is incorporated into clinical formulations for and relief, where it helps stabilize postprandial glucose levels and alleviate bowel dysfunction without significantly impacting overall energy intake. Studies in clinical settings demonstrate that 12 g per day of polydextrose supplementation increases defecation frequency and improves bowel symptoms such as straining and completeness in adults with , while also attenuating glycemic excursions in those with impaired glucose tolerance. These applications are particularly valuable in enteral nutrition products for hospitalized patients, where polydextrose supports metabolic control alongside its mild laxative effects. Emerging applications of polydextrose include its addition to formulas to foster early development, mimicking the prebiotic effects observed in . Enrichment with up to 2 grams per liter of polydextrose (in a 1:1 blend with galacto-oligosaccharides), promotes bifidogenic growth in the gut, increasing lactobacilli populations and lowering ileal to enhance microbial balance during the critical first months of life; its use in formulas is regulated, with approval at up to 2 g/L in the under GRAS Notice No. 233. Clinical trials confirm that such formulas support stool consistency and composition comparable to outcomes, without adverse effects on growth. Polydextrose is integrated with other dietary fibers, such as or soluble maize fiber, in functional foods designed to target and by modulating and . This combination, at doses of 10-15 grams daily, has been evidenced to reduce fasting and adipose in high-fat diet models, improving insulin sensitivity and lowering levels in individuals with metabolic risks. Such synergistic formulations in bars or shakes enhance and , providing a practical approach to .

Safety, Regulation, and History

Safety Profile and Side Effects

Polydextrose is (GRAS) for use in food by the U.S. under 21 CFR 172.841, with no need for a numerical (ADI) as affirmed by the (EFSA) and the Joint FAO/WHO Expert Committee on Food Additives (JECFA). Long-term have demonstrated no evidence of , including negative results in bacterial assays, chromosomal aberration tests in human lymphocytes and mouse bone marrow, and dominant lethal assays in mice at doses up to 2 g/kg body weight. Similarly, no carcinogenicity was observed in 18-month mouse studies at up to 15,000 mg/kg body weight per day or 24-month rat studies at up to 5,000 mg/kg body weight per day, with no increase in tumor incidence compared to controls. Common side effects of polydextrose consumption are primarily gastrointestinal and include , , and , which arise from its partial in the colon producing and gases. These effects are dose-dependent and typically mild and transient; nine clinical studies in adults and children established a mean threshold of approximately 90 g per person per day or 50 g as a single dose, with no significant symptoms at intakes up to 15 g per day. Polydextrose is better tolerated than many polyols, such as , due to its higher molecular weight and slower rate, and symptoms resolve upon dose reduction. Human trials indicate no adverse impact on mineral absorption, with studies showing neutral or even enhanced retention of calcium and iron at typical doses. No drug interactions have been reported in clinical investigations. For sensitive populations, such as individuals with (IBS), polydextrose may exacerbate gastrointestinal discomfort at higher doses due to increased gas production from , though generally well-tolerated in moderation. Children and those with pre-existing digestive sensitivities do not appear more susceptible on a body weight basis compared to healthy adults.

Regulatory Status and Historical Development

Polydextrose was invented in the late by researchers at Central Research, led by Hans H. Rennhard, who developed it as a low-calorie bulking agent to replace and in food products while providing fiber-like properties. The invention addressed the need for a non-digestible with minimal caloric impact, and it was patented in 1973. Following development, polydextrose was first commercialized in 1981, marking its entry into the as a versatile ingredient. In the United States, the (FDA) approved polydextrose for use as a in 1981 under 21 CFR 172.841, allowing it as a bulking agent, formulation aid, , and texturizer in various foods at levels consistent with good manufacturing practices. This approval established its safety for general food use without specific quantity limits. In 2018, the FDA issued guidance recognizing polydextrose as a source of for labeling purposes, exercising enforcement discretion to permit its inclusion on labels. As of 2024, the FDA continues to exercise enforcement discretion for polydextrose as a source. In the , polydextrose has been approved as a under the designation E 1200 since 2000, permitting its use in a wide range of products at levels, meaning as much as needed to achieve the intended effect without maximum limits. The Joint FAO/WHO Expert Committee on Food Additives (JECFA) evaluated polydextrose in 1987 and established an (ADI) of "not specified," indicating no safety concerns at levels conforming to good manufacturing practices. Over time, regulatory perspectives on polydextrose have evolved to recognize its potential health benefits beyond basic safety. In recent years, the (EFSA) has assessed health claims related to its prebiotic effects, noting in evaluations such as the 2021 re-assessment that polydextrose exhibits prebiotic characteristics by modulating and supporting beneficial short-chain fatty acid production, particularly in contexts like enrichment. This progression reflects growing scientific consensus on its physiological roles, influencing labeling allowances for and gut health in multiple jurisdictions.

References

Add your contribution
Related Hubs
User Avatar
No comments yet.